Effect of high WDR5 expression on the hepatocellular carcinoma prognosis

被引:18
|
作者
Cui, Zhoujun [1 ]
Li, Hongbo [1 ]
Liang, Feng [1 ]
Mu, Cuiling [1 ]
Mu, Yuhua [1 ]
Zhang, Xuegong [1 ]
Liu, Jundong [1 ]
机构
[1] Peoples Hosp Rizhao, Dept Gen Surg, 126 Taian Rd, Rizhao 276800, Shandong, Peoples R China
关键词
hepatocellular carcinoma; WD repeat domain 5; histone H3 lysine 4; short hairpin RNA; prognosis; HISTONE H3; CANCER STATISTICS; LYSINE; 4; EZH2; METHYLATION; PROSTATE; MLL1;
D O I
10.3892/ol.2018.8298
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
WD repeat domain 5 (WDR5) serves an important role in various biological functions through the epigenetic regulation of gene transcription. Aberrant expression of WDR5 has been observed in various types of human cancer, including prostate cancer, breast cancer and leukemia. However, the role of WDR5 expression and its clinical implications in hepatocellular carcinoma (HCC) remain largely unknown. The present study investigated the WDR5 expression pattern in HCC. It was demonstrated that the mRNA and protein levels of WDR5 were upregulated in HCC cancer tissues compared with normal adjacent tissues using reverse transcription-quantitative polymerase chain reaction and western blotting. Furthermore, the elevated WDR5 protein level was significantly associated with the histological grade (P=0.038), tumor size (P=0.023), tumor-node-metastasis stage (P=0.035) and reduced long-term survival time. Additionally, it was demonstrated through the shRNA-mediated knockdown of WDR5 in HCC cells in vitro that WDR5 expression promotes cell proliferation using an MTT assay. Taken together, the results suggested that WDR5 overexpression may have an oncogenic effect in HCC, and may be a promising biomarker for the diagnosis and prognosis of HCC.
引用
收藏
页码:7864 / 7870
页数:7
相关论文
共 50 条
  • [21] WDR5 facilitates recruitment of N-MYC to conserved WDR5 gene targets in neuroblastoma cell lines
    Leigh A. Bumpous
    Kylie C. Moe
    Jing Wang
    Logan A. Carver
    Alexandria G. Williams
    Alexander S. Romer
    Jesse D. Scobee
    Jack N. Maxwell
    Cheyenne A. Jones
    Dai H. Chung
    William P. Tansey
    Qi Liu
    April M. Weissmiller
    Oncogenesis, 12
  • [22] Wdr5 Is Required for Chick Skeletal Development
    Zhu, Shimei
    Zhu, Eric D.
    Provot, Sylvain
    Gori, Francesca
    JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (11) : 2504 - 2514
  • [23] WDR5 facilitates recruitment of N-MYC to conserved WDR5 gene targets in neuroblastoma cell lines
    Bumpous, Leigh A.
    Moe, Kylie C.
    Wang, Jing
    Carver, Logan A.
    Williams, Alexandria G.
    Romer, Alexander S.
    Scobee, Jesse D.
    Maxwell, Jack N.
    Jones, Cheyenne A.
    Chung, Dai H.
    Tansey, William P.
    Liu, Qi
    Weissmiller, April M.
    ONCOGENESIS, 2023, 12 (01)
  • [24] Small molecule WDR5 inhibitors down-regulate lncRNA expression
    Chang, Jen-Yao
    Neugebauer, Cora
    Koers, Anne Mues Genannt
    't Hart, Peter
    RSC MEDICINAL CHEMISTRY, 2024, 15 (02): : 636 - 640
  • [25] Wdr5 is essential for fetal erythropoiesis and hematopoiesis
    Liu, Lulu
    Fang, Yanjia
    Ding, Xiaodan
    Zhou, Weihua
    Terranova, Remi
    Zhang, Yan
    Wang, He
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [26] Wdr5 is essential for fetal erythropoiesis and hematopoiesis
    Lulu Liu
    Yanjia Fang
    Xiaodan Ding
    Weihua Zhou
    Remi Terranova
    Yan Zhang
    He Wang
    Experimental Hematology & Oncology, 12
  • [27] HBx/WDR5 enhances IGF-1 transcription in hepatocellular carcinoma cells and promotes recruitment, infiltration, and activity of Treg cells
    Wang, Erli
    Sun, Shuhua
    Li, Hui
    Jia, Yi
    Bai, Zhe
    IMMUNOLOGIC RESEARCH, 2025, 73 (01)
  • [28] Defining the molecular context of MYC and WDR5 at chromatin
    Guarnaccia, Alissa D.
    Tansey, William P.
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Effect of high expression of fatty acid binding protein 5 on prognosis and epithelial-mesenchymal transition in hepatocellular carcinoma
    Ohata, Takanori
    Yokoo, Hideki
    Kamiyama, Toshiya
    Aiyama, Takeshi
    Wakayama, Kenji
    Orimo, Tatsuya
    Kakisaka, Tatsuhiko
    Tsuruga, Yousuke
    Kamachi, Hirofumi
    Taketomi, Akinobu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [30] Impact of WIN site inhibitor on the WDR5 interactome
    Guarnaccia, Alissa D.
    Rose, Kristie L.
    Wang, Jing
    Zhao, Bin
    Popay, Tessa M.
    Wang, Christina E.
    Guerrazzi, Kiana
    Hill, Salisha
    Woodley, Chase M.
    Hansen, Tyler J.
    Lorey, Shelly L.
    Shaw, J. Grace
    Payne, William G.
    Weissmiller, April M.
    Olejniczak, Edward T.
    Fesik, Stephen W.
    Liu, Qi
    Tansey, William P.
    CELL REPORTS, 2021, 34 (03):